Dudediligence.

ORIC Pharmaceuticals, Inc

ORICNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$34.6MSep ’24−$36.3MDec ’24−$30.0MMar ’25−$36.4MJun ’25−$32.6MSep ’25−$30.5MDec ’25−$35.8MMar ’26−$41.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$78.9M−$91.8M−$110.8M−$142.9M−$143.0M
Net income−$78.7M−$89.1M−$100.7M−$127.8M−$129.5M
Operating cash flow−$59.5M−$75.1M−$85.7M−$112.7M−$111.0M
Free cash flow−$60.5M−$77.2M−$86.5M−$113.8M−$111.7M
Cash$226.0M$66.8M$23.4M$59.4M$45.7M
Debt$10.5Mnone on filenone on filenone on filenone on file
Shares outstanding39.4M45.1M54.9M71.0M98.5M